Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recent innovations in asthma therapy.

E O Vianna¹, R J Martin

¹Department of Medicine, National Jewish Medical and Research Center, Denver, Colorado 80206, USA.

Drugs of Today (Barcelona, Spain : 1998)

|March 11, 2004

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Biomass smoke COPD has less tomographic abnormalities but worse hypoxemia compared with tobacco COPD.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2019

Same author

Cat ownership is associated with increased asthma prevalence and dog ownership with decreased spirometry values.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2018

Same author

Allergic sensitization to laboratory animals is more associated with asthma, rhinitis, and skin symptoms than sensitization to common allergens.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017

Same author

Fluticasone/formoterol dry powder versus budesonide/formoterol in adults and adolescents with uncontrolled or partly controlled asthma.

Respiratory medicine·2013

Same author

Effects of ipratropium on exercise-induced bronchospasm.

International journal of sports medicine·2010

Same author

Impact of specific sensitization on asthma and rhinitis in young Brazilian and Chilean adults.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2008

New anti-leukotriene agents, like zafirlukast and montelukast, improve asthma control by reducing inflammation and exacerbations. Phosphodiesterase inhibitors are also being investigated for their bronchodilating and anti-inflammatory effects in asthma management.

Area of Science:

Pulmonology
Pharmacology

Background:

Asthma management guidelines have evolved since 1990, emphasizing objective measures, environmental control, pharmacologic therapy, and patient education.
Newly developed medications target airway inflammation, a key characteristic of asthma.

Purpose of the Study:

To review the efficacy of novel anti-leukotriene agents and phosphodiesterase inhibitors in asthma management.
To discuss the mechanisms of action and clinical outcomes associated with these new asthma therapies.

Main Methods:

Review of clinical studies on anti-leukotriene agents (zafirlukast, pranlukast, montelukast, zileuton).
Discussion of in vitro and animal model studies on phosphodiesterase (PDE) inhibitors.
Analysis of effects on pulmonary function, symptoms, exacerbations, and medication use.

Related Experiment Videos

Main Results:

Anti-leukotriene receptor antagonists (zafirlukast, pranlukast, montelukast) improve lung function, reduce symptoms, and decrease exacerbation frequency.
Leukotriene synthesis inhibitors (zileuton) also improve lung function and reduce exacerbations, with potential liver function concerns.
PDE inhibitors show potential for bronchodilation and anti-inflammatory effects, requiring further clinical trials.

Conclusions:

Anti-leukotriene agents offer a promising therapeutic option for asthma, potentially complementing or serving as alternatives to inhaled corticosteroids.
Further clinical research is essential to establish the role of PDE inhibitors in asthma treatment.